您当前的位置：
首页 >
文章列表页 >
Interpretation of Chinese guideline for the clinical application of noninvasive imaging technology in accessing cancer therapy-related cardiovascular toxicity (2023 edition)
更新时间：2025-12-15

    • Interpretation of Chinese guideline for the clinical application of noninvasive imaging technology in accessing cancer therapy-related cardiovascular toxicity (2023 edition)

    • “According to the Clinical Application Guidelines for Non invasive Imaging Techniques in Evaluating Cardiovascular Toxicity Related to Tumor Therapy (2023 Edition) released by the China Anti Cancer Association and other institutions, non-invasive imaging examinations play an important role in clinical risk stratification, early diagnosis and treatment, monitoring, and follow-up of cardiovascular toxicity related to tumor therapy, providing practical guidance for clinical management work.”
    • Oncoradiology   Vol. 34, Issue 1, Pages: 1-10(2025)

    • DOI：10.19732/j.cnki.2096-6210.2025.01.001    

      CLC：

    • Received：10 January 2025，

      Published Online：13 March 2025，

      Published：28 February 2025

    移动端阅览

  • Yezi CHAI, Meng JIANG, Jun PU. Interpretation of Chinese guideline for the clinical application of noninvasive imaging technology in accessing cancer therapy-related cardiovascular toxicity (2023 edition)[J]. Oncoradiology, 2025, 34(1): 1-10. DOI： 10.19732/j.cnki.2096-6210.2025.01.001.

  •  
  •  

0

Views

353

下载量

1

CNKI被引量

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Fine-needle aspiration biopsy of thyroid nodules: performances of ACR TI-RADS and ATA guideline
CT manifestations of ovarian clear cell carcinoma
A motor-driven target replacement device in the multi-targetion source of accelerator
Analyses of the IBAD MoS2-Ta films by TEM and energyspectrum techniques
Study on REE bound water-soluble polysaccharides in plant

Related Author

GAO Luying
DA Wa
ZHANG Bo
LI Xiaoyi
LIAO Quan
MA Liyuan
SHI Xinlong
LIU Ruifeng

Related Institution

Department of Ultrasound, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Ultrasound, Tibet Autonomous Region People&rsquo
Department of Ultrasound, China-Japan Friendship Hospital
Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
0